Grafts

Axolotl Graft™ & Axolotl DualGraft™ 

Axolotl Graft™ and Axolotl DualGraft™ are dehydrated human amnion membrane allografts derived from the amniotic lining of the placenta. Axolotl Graft™ and Axolotl DualGraft™ are indicated as a wound covering and structural barrier. Axolotl graft products are processed through minimal manipulation techniques, retaining the native qualities of the amniotic membrane to function as a wound covering and as a structural barrier. Axolotl Graft™ and Axolotl DualGraft™ are marketed under Section 361 of the PHS act and regulated under 21 CFR Part 1271.  Axolotl graft products have received a letter of recommendation from the FDA Tissue Reference Group (TRG) and are manufactured in an AATB accredited manufacturing environment.  For reimbursement information, please visit CMS 2023 ASP Drug Pricing Files.

More Information:
Axolotl Graft™ Brochure
Axolotl DualGraft™ Brochure
Axolotl Dualgraft Application Guide